RU2004115757A - Стенты - Google Patents
Стенты Download PDFInfo
- Publication number
- RU2004115757A RU2004115757A RU2004115757/15A RU2004115757A RU2004115757A RU 2004115757 A RU2004115757 A RU 2004115757A RU 2004115757/15 A RU2004115757/15 A RU 2004115757/15A RU 2004115757 A RU2004115757 A RU 2004115757A RU 2004115757 A RU2004115757 A RU 2004115757A
- Authority
- RU
- Russia
- Prior art keywords
- stents
- formula
- compounds
- thrombosis
- stenosis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims 9
- 208000031481 Pathologic Constriction Diseases 0.000 claims 5
- 208000007536 Thrombosis Diseases 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 208000037804 stenosis Diseases 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 230000036262 stenosis Effects 0.000 claims 3
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 claims 2
- -1 chloro, bromo, methyl Chemical group 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 238000007910 systemic administration Methods 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 claims 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- KGFYHTZWPPHNLQ-AWEZNQCLSA-N rivaroxaban Chemical compound S1C(Cl)=CC=C1C(=O)NC[C@@H]1OC(=O)N(C=2C=CC(=CC=2)N2C(COCC2)=O)C1 KGFYHTZWPPHNLQ-AWEZNQCLSA-N 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10152460A DE10152460A1 (de) | 2001-10-24 | 2001-10-24 | Stents |
| DE10152460.9 | 2001-10-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2004115757A true RU2004115757A (ru) | 2005-04-10 |
Family
ID=7703557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004115757/15A RU2004115757A (ru) | 2001-10-24 | 2002-10-11 | Стенты |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050064006A1 (enExample) |
| EP (1) | EP1439869A1 (enExample) |
| JP (1) | JP2005506151A (enExample) |
| KR (1) | KR20040074977A (enExample) |
| CN (1) | CN1575189A (enExample) |
| AU (1) | AU2002340549B2 (enExample) |
| BR (1) | BR0213481A (enExample) |
| CA (1) | CA2464290A1 (enExample) |
| DE (1) | DE10152460A1 (enExample) |
| EC (1) | ECSP045075A (enExample) |
| EE (1) | EE200400080A (enExample) |
| HR (1) | HRP20040456A2 (enExample) |
| HU (1) | HUP0401760A3 (enExample) |
| IL (1) | IL161445A0 (enExample) |
| MA (1) | MA26341A1 (enExample) |
| MX (1) | MXPA04003755A (enExample) |
| NO (1) | NO20041984L (enExample) |
| NZ (1) | NZ532443A (enExample) |
| PL (1) | PL367968A1 (enExample) |
| RU (1) | RU2004115757A (enExample) |
| WO (1) | WO2003035133A1 (enExample) |
| ZA (1) | ZA200402989B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
| DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
| DE10355461A1 (de) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
| EP1685841A1 (en) * | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
| DE102005045518A1 (de) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
| NZ567092A (en) | 2005-10-04 | 2011-05-27 | Bayer Schering Pharma Ag | Novel polymorphous form and the amorphous form of 5-chloro-N-({ (5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
| DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
| US20070097252A1 (en) * | 2005-10-31 | 2007-05-03 | Silverstein D A | Imaging methods, cameras, projectors, and articles of manufacture |
| DE102006034916A1 (de) * | 2006-07-28 | 2008-01-31 | Bayer Healthcare Ag | Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten |
| DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
| US8741890B2 (en) | 2007-11-15 | 2014-06-03 | Boehringer Ingelheim International Gmbh | Substituted amides, manufacturing and use thereof as medicaments |
| WO2021242783A1 (en) * | 2020-05-26 | 2021-12-02 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
| US11654036B2 (en) | 2020-05-26 | 2023-05-23 | Elixir Medical Corporation | Anticoagulant compounds and methods and devices for their use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE181735T1 (de) * | 1993-05-01 | 1999-07-15 | Merck Patent Gmbh | Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten |
| CA2285705A1 (en) * | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | Selective factor xa inhibitors |
| US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
| US20010029351A1 (en) * | 1998-04-16 | 2001-10-11 | Robert Falotico | Drug combinations and delivery devices for the prevention and treatment of vascular disease |
| DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| DE10105989A1 (de) * | 2001-02-09 | 2002-08-14 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
-
2001
- 2001-10-24 DE DE10152460A patent/DE10152460A1/de not_active Withdrawn
-
2002
- 2002-02-11 IL IL16144502A patent/IL161445A0/xx unknown
- 2002-10-11 US US10/493,552 patent/US20050064006A1/en not_active Abandoned
- 2002-10-11 RU RU2004115757/15A patent/RU2004115757A/ru not_active Application Discontinuation
- 2002-10-11 WO PCT/EP2002/011402 patent/WO2003035133A1/de not_active Ceased
- 2002-10-11 HU HU0401760A patent/HUP0401760A3/hu unknown
- 2002-10-11 BR BR0213481-0A patent/BR0213481A/pt not_active IP Right Cessation
- 2002-10-11 NZ NZ532443A patent/NZ532443A/en unknown
- 2002-10-11 HR HR20040456A patent/HRP20040456A2/hr not_active Application Discontinuation
- 2002-10-11 CA CA002464290A patent/CA2464290A1/en not_active Abandoned
- 2002-10-11 PL PL02367968A patent/PL367968A1/xx not_active Application Discontinuation
- 2002-10-11 KR KR10-2004-7006051A patent/KR20040074977A/ko not_active Ceased
- 2002-10-11 JP JP2003537695A patent/JP2005506151A/ja active Pending
- 2002-10-11 AU AU2002340549A patent/AU2002340549B2/en not_active Ceased
- 2002-10-11 MX MXPA04003755A patent/MXPA04003755A/es not_active Application Discontinuation
- 2002-10-11 EE EEP200400080A patent/EE200400080A/xx unknown
- 2002-10-11 CN CNA028210034A patent/CN1575189A/zh active Pending
- 2002-10-11 EP EP02774699A patent/EP1439869A1/de not_active Withdrawn
-
2004
- 2004-04-20 ZA ZA200402989A patent/ZA200402989B/en unknown
- 2004-04-22 EC EC2004005075A patent/ECSP045075A/es unknown
- 2004-04-23 MA MA27648A patent/MA26341A1/fr unknown
- 2004-05-13 NO NO20041984A patent/NO20041984L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ532443A (en) | 2005-11-25 |
| MXPA04003755A (es) | 2004-07-23 |
| ECSP045075A (es) | 2004-05-28 |
| CA2464290A1 (en) | 2003-05-01 |
| MA26341A1 (fr) | 2004-10-01 |
| HRP20040456A2 (en) | 2005-06-30 |
| US20050064006A1 (en) | 2005-03-24 |
| JP2005506151A (ja) | 2005-03-03 |
| AU2002340549B2 (en) | 2007-11-29 |
| HUP0401760A2 (hu) | 2004-12-28 |
| ZA200402989B (en) | 2005-04-20 |
| DE10152460A1 (de) | 2003-05-08 |
| WO2003035133A1 (de) | 2003-05-01 |
| KR20040074977A (ko) | 2004-08-26 |
| NO20041984L (no) | 2004-05-13 |
| BR0213481A (pt) | 2004-11-03 |
| EP1439869A1 (de) | 2004-07-28 |
| PL367968A1 (en) | 2005-03-07 |
| EE200400080A (et) | 2004-08-16 |
| HUP0401760A3 (en) | 2008-04-28 |
| CN1575189A (zh) | 2005-02-02 |
| IL161445A0 (en) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2004115757A (ru) | Стенты | |
| RU2004101404A (ru) | Комбинированная терапия с помощью замещенных оксазолидинов | |
| RU2310648C2 (ru) | 5-замещенные пиразиновые или пиридиновые активаторы глюкокиназы | |
| PE20090884A1 (es) | Compuestos de indol como activadores de glucoquinasa | |
| JP2005506151A5 (enExample) | ||
| CO5280079A1 (es) | Nuevos compuestos | |
| PE20091042A1 (es) | Ligandos de oxadiazol del receptor metabotropico del glutamato y su uso como potenciadores - 841 | |
| PE20090617A1 (es) | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa | |
| RU2004122102A (ru) | Новые производные бензимидазола и их применение в качестве лекарственных препаратов | |
| RU95112537A (ru) | Терапевтические гетероциклические соединения, способ их получения, фармацевтическая композиция, способ ее получения | |
| AR019626A1 (es) | Antagonistas receptores y5 de neuropeptidos. | |
| HRP20080150T3 (en) | Method for the production of a solid, orally applicable pharmaceutical composition comprising 5-chlor-n({(5-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamide | |
| EA200300323A1 (ru) | ПРОИЗВОДНЫЕ ГУАНИДИНОБЕНЗАМИДА (ВАРИАНТЫ), КОМПОЗИЦИЯ (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ ОПОСРЕДОВАННОГО mc4-r ЗАБОЛЕВАНИЯ (ВАРИАНТЫ) | |
| PE20020589A1 (es) | 5-espiropirimidin-2,4,6-triona como inhibidores de metaloproteinasas | |
| RU2008138649A (ru) | Применение а1-агонистов аденозина и/или двойных а1/а2в-агонистов аденозина для получения лекарственных средств для лечения заболеваний | |
| RU2008118100A (ru) | Лечение и профилактика микроангиопатий | |
| DE59410181D1 (de) | Neue thiazolidindione und diese enthaltende arzneimittel | |
| AR039190A1 (es) | Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto | |
| PE20041078A1 (es) | Derivados heterociclicos inhibidores de la elastasa leucocitica humana (elh) | |
| RU2006144069A (ru) | Режим приема контрацептива с антагонистом рецептора прогестерона и набор для приема | |
| SE0201937D0 (sv) | Therapeutic agents | |
| RU2005135441A (ru) | Соединения для лечения метаболических расстройств | |
| JP2005519885A5 (enExample) | ||
| KR940702491A (ko) | 옥사졸리돈 유도체 | |
| PE20091348A1 (es) | Derivados de 1,2,4-triazol amino como moduladores de mglur5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20070309 |